PRCT logo

PROCEPT BioRobotics (PRCT)

Profile

Full Name

PROCEPT BioRobotics Corporation

Ticker Symbol

PRCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

September 15, 2021

Indexes

Not included

Website

http://www.procept-biorobotics.com

Employees

756

Key Details

Price

$52.92(-1.56%)

Market cap

$2.90B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$224.50M(+64.84% YoY)

Annual EPS

-$1.75(+21.88% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$52.92
PRCT price is $52.92

30-Day Relative Volume

0.84
PRCT 30-day relative volume is 0.84

Price Performance

Price Today change

-1.56%
PRCT price is down -1.56% today

Price YTD change

-34.28%
PRCT price is down -34.28% since January 1st

Price 1-year change

+4.58%
PRCT price is up +4.58% year-on-year

Price 3-year change

+42.76%
PRCT price is up +42.76% over the past 3 years

Price Range

Price All-time high

$103.81
PRCT price is currently -49.02% below its historical high of $103.81

Price 3-year low

$24.83
PRCT price is currently +113.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.90B
PRCT market capitalization is $2.90 billion

Market cap 3-year change

+77.41%
PRCT market capitalization is up +77.41% over the past 3 years

Market cap All-time high

$5.40B
PRCT market capitalization is currently -46.24% below its historical high of $5.40 billion

Market cap sector rank

86.27%
PRCT market capitalization is higher than 86.27% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.65%
PRCT shares outstanding is up +6.65% year-on-year

Shares Outstanding 3-Year Change

+24.27%
PRCT shares outstanding is up +24.27% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.16
PRCT beta is 1.16

200-day SMA

$73.78
PRCT price is currently -28.28% below its 200-day simple moving average

50-day SMA

$60.99
PRCT price is currently -13.23% below its 50-day simple moving average

RSI

42.34
PRCT 14-day relative strength index is 42.34

Volume

0.84
PRCT 30-day relative volume is 0.84

ATR

$3.82
PRCT average true range is $3.82

10-day Historical Volatility

91.38%
PRCT 10-day historical volatility is 91.38%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$224.50M
PRCT annual revenue is $224.50 million

Revenue Analysts estimate

$321.67M
PRCT annual revenue is currently -30.21% lower than the consensus analysts' forecast

Revenue 1-year change

+64.84%
PRCT annual revenue is up +64.84% year-on-year

Revenue Sector rank

65.73%
PRCT annual revenue is higher than 65.73% of companies in Healthcare sector

EPS

EPS

-$1.75
PRCT annual earnings per share is -$1.75

EPS Analysts estimate

-$1.52
PRCT annual earnings per share is currently +15.32% higher than the consensus analysts' forecast

EPS 1-year change

+21.88%
PRCT annual earnings per share is up +21.88% year-on-year

EPS Sector rank

41.11%
PRCT annual earnings per share is higher than 41.11% of companies in Healthcare sector

Profit

Gross profit

$137.10M
PRCT annual gross profit is $137.10 million

Gross margin

61.07%
PRCT annual gross profit margin is 61.07%

Operating profit

-$96.61M
PRCT annual operating income is -$96.61 million

Operating margin

-43.04%
PRCT annual operating profit margin is -43.04%

Net income

-$91.41M
PRCT annual net profit is -$91.41 million

Net margin

-40.72%
PRCT annual net profit margin is -40.72%

Expenses

Total expenses

$321.11M
PRCT annual total expenses is $321.11 million

Operating expenses

$233.71M
PRCT annual total operating expenses is $233.71 million

Cost of goods sold

$87.40M
PRCT annual cost of goods sold is $87.40 million

Selling, general & administrative expenses

$171.41M
PRCT annual SGA is $171.41 million

Depreciation and amortization

$5.23M
PRCT annual depreciation & amortization is $5.23 million

Interest expense

$4.18M
PRCT annual interest expense is $4.18 million

Income tax

-
PRCT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$87.23M
PRCT annual earnings before interest & taxes is -$87.23 million

EBITDA

-$87.23M
PRCT annual EBITDA is -$87.23 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$534.02M
PRCT annual total assets is $534.02 million

Non current assets

$52.17M
PRCT annual long term assets is $52.17 million

Current assets

$481.84M
PRCT annual total current assets is $481.84 million

Cash and cash equivalents

$333.73M
PRCT annual cash & cash equivalents is $333.73 million

Accounts receivable

$83.50M
PRCT annual accounts receivable is $83.50 million

Inventory

$56.17M
PRCT annual inventory is $56.17 million

Liabilities

Total liabilities

$131.80M
PRCT annual total liabilities is $131.80 million

Long term liabilities

$78.66M
PRCT annual total long term liabilities is $78.66 million

Current liabilities

$53.13M
PRCT annual total current liabilities is $53.13 million

Accounts payable

$10.03M
PRCT annual accounts payable is $10.03 million

Debt

Total debt

$80.25M
PRCT annual total debt is $80.25 million

Total debt 1-year change

+1.32%
PRCT annual total debt is up +1.32% year-on-year

Long term debt

$78.34M
PRCT annual long term debt is $78.34 million

Short term debt

$1.91M
PRCT annual short term debt is $1.91 million

Equity & Capital

Shareholders equity

$402.22M
PRCT annual stockholders equity is $402.22 million

Book value

$402.22M
PRCT annual book value is $402.22 million

Retained earnings

-$545.99M
PRCT annual retained earnings is -$545.99 million

Working capital

$428.71M
PRCT annual working capital is $428.71 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$99.21M
PRCT annual cash flow from operations is -$99.21 million

Cash from operations 1-year change

+8.14%
PRCT annual cash flow from operations is up +8.14% year-on-year

Cash from investing

-$4.41M
PRCT annual cash flow from investing activities is -$4.41 million

Cash from investing 1-year change

+82.51%
PRCT annual cash flow from investing activities is up +82.51% year-on-year

Cash from financing

$180.13M
PRCT annual cash flow from financing activities is $180.13 million

Cash from financing 1-year change

+7.35%
PRCT annual cash flow from financing activities is up +7.35% year-on-year

CAPEX

CAPEX

$4.41M
PRCT annual capital expenditures is $4.41 million

CAPEX 1-year change

-82.51%
PRCT annual capital expenditures is down -82.51% year-on-year

Free Cash Flow

Free cash flow

-$103.62M
PRCT annual free cash flow is -$103.62 million

Free cash flow 1-year change

+22.21%
PRCT annual free cash flow is up +22.21% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

61.07%
PRCT annual gross profit margin is 61.07%

Operating margin

-43.04%
PRCT annual operating profit margin is -43.04%

Net margin

-40.72%
PRCT annual net profit margin is -40.72%

ROA & ROE

ROA

-19.48%
PRCT annual return on assets is -19.48%

ROE

-26.77%
PRCT annual return on equity is -26.77%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PRCT price to earnings ratio value is unknown

PE ratio Sector rank

-
PRCT price to earnings ratio is unknown

PB Ratio

PB ratio

7.21
PRCT price to book ratio is 7.21

PB ratio Sector rank

88.97%
PRCT price to book ratio is higher than 88.97% of companies in Healthcare sector

PS Ratio

PS ratio

12.92
PRCT price to sales ratio is 12.92

PS ratio Sector rank

82.69%
PRCT price to sales ratio is higher than 82.69% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.65B
PRCT enterprise value is $2.65 billion

Enterprise value Sector rank

84.3%
PRCT enterprise value is higher than 84.3% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-31.73
PRCT EV/EBITDA is -31.73

EV/EBITDA Sector rank

4.52%
PRCT EV/EBITDA is higher than 4.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.07
PRCT annual current ratio is 9.07

Quick ratio

8.01
PRCT annual quick ratio is 8.01

Leverage

Debt to equity

0.13
PRCT annual debt to equity ratio is 0.13

Interest coverage ratio

-20.85
PRCT annual interest coverage ratio is -20.85

Risk & Stability

Piotroski F-Score

3
PRCT piotroski f-score is 3

Altman Z-Score

12.62
PRCT altman z-score is 12.62

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Buy
Feb 26, 25 Truist Securities
Buy
Feb 26, 25 Morgan Stanley
Overweight
Dec 2, 24 Morgan Stanley
Overweight
Nov 14, 24 Jefferies
Hold
Oct 30, 24 Truist Securities
Buy
Oct 8, 24 Piper Sandler
Overweight
Sep 16, 24 TD Cowen
Buy
Sep 3, 24 Truist Securities
Buy
Aug 22, 24 B of A Securities
Buy

Institutional Ownership

Similar stocks

MRUS logo
Merus NV (MRUS)
TMDX logo
TransMedics (TMDX)
OGN logo
Organon & Co (OGN)
HAE logo
Haemonetics (HAE)
BTSG logo
BrightSpring Health Services (BTSG)
AKRO logo
Akero Therapeutics (AKRO)
PRVA logo
Privia Health (PRVA)
AMED logo
Amedisys (AMED)
SHC logo
Sotera Health (SHC)
  • What is the ticker symbol for PROCEPT BioRobotics?
  • Does PROCEPT BioRobotics pay dividends?
  • What sector is PROCEPT BioRobotics in?
  • What industry is PROCEPT BioRobotics in?
  • What country is PROCEPT BioRobotics based in?
  • When did PROCEPT BioRobotics go public?
  • Is PROCEPT BioRobotics in the S&P 500?
  • Is PROCEPT BioRobotics in the NASDAQ 100?
  • Is PROCEPT BioRobotics in the Dow Jones?
  • When was PROCEPT BioRobotics's last earnings report?
  • When does PROCEPT BioRobotics report earnings?
  • Should I buy PROCEPT BioRobotics stock now?

What is the ticker symbol for PROCEPT BioRobotics?

The ticker symbol for PROCEPT BioRobotics is NASDAQ:PRCT

Does PROCEPT BioRobotics pay dividends?

No, PROCEPT BioRobotics does not pay dividends

What sector is PROCEPT BioRobotics in?

PROCEPT BioRobotics is in the Healthcare sector

What industry is PROCEPT BioRobotics in?

PROCEPT BioRobotics is in the Medical Devices industry

What country is PROCEPT BioRobotics based in?

PROCEPT BioRobotics is headquartered in United States

When did PROCEPT BioRobotics go public?

PROCEPT BioRobotics's initial public offering (IPO) was on September 15, 2021

Is PROCEPT BioRobotics in the S&P 500?

No, PROCEPT BioRobotics is not included in the S&P 500 index

Is PROCEPT BioRobotics in the NASDAQ 100?

No, PROCEPT BioRobotics is not included in the NASDAQ 100 index

Is PROCEPT BioRobotics in the Dow Jones?

No, PROCEPT BioRobotics is not included in the Dow Jones index

When was PROCEPT BioRobotics's last earnings report?

PROCEPT BioRobotics's most recent earnings report was on Feb 25, 2025

When does PROCEPT BioRobotics report earnings?

The next expected earnings date for PROCEPT BioRobotics is May 1, 2025

Should I buy PROCEPT BioRobotics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page